PMID: 2486554Sep 1, 1989Paper

Acute changes in renal function associated with deferoxamine therapy

American Journal of Diseases of Children
G KorenM H Freedman

Abstract

In three patients who received intravenous deferoxamine there was a twofold to eightfold increase in plasma creatinine level and a parallel decrease in creatinine clearance that resolved when treatment with the drug was discontinued. In two thalassemic patients, diuresis was evident by urine output exceeding fluid intake. The mechanism was studied in dogs that exhibited an acute and significant decrease in inulin and para-aminohippuric acid clearances induced by intravenous deferoxamine. Saline diuresis could prevent the decrease in the glomerular filtration rate but not the decrease in renal blood flow caused by deferoxamine. Deferoxamine induced an acute increase in the fractional excretion of sodium, potassium, chloride, phosphate, and urate, which may explain the relative diuresis observed in two of the patients. In a subsequent experiment, ferrioxamine induced an increase in the fractional excretion of sodium and chloride but did not affect the glomerular filtration rate and renal blood flow. Our studies suggest that adequate hydration may be needed to preserve renal hemodynamics during intravenous deferoxamine therapy. Repeated measurements of renal function should accompany treatment with this agent.

Citations

Jul 30, 2014·Hematology/oncology Clinics of North America·Maria Marsella, Caterina Borgna-Pignatti
Jun 10, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Dur-Zong HsuMing-Yie Liu
Mar 19, 2003·Clinical and Laboratory Haematology·G KoliakosM Athanasiou
Jun 13, 2012·European Journal of Haematology·Sunil Bhandari, Renzo Galanello
Feb 22, 2011·British Journal of Haematology·Charles T QuinnUNKNOWN Thalassemia Clinical Research Network
Dec 1, 1994·Baillière's Clinical Haematology·V Gabutti, C Borgna-Pignatti
Jan 1, 1991·The Journal of Pediatrics·Y BenturG Koren
Jun 20, 1998·British Journal of Haematology·C HershkoG Link
Nov 29, 2016·European Journal of Haematology·Sebastian BotzenhardtAntje Neubert
Jun 19, 2013·Circulation·Dudley J PennellUNKNOWN American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council
May 22, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·John B PorterFelicia Trachtenberg
Jun 27, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Vladislav SmolkinAriel Koren
Nov 28, 2001·Hematology·J P KushnerN F Olivieri
Oct 7, 2011·Pediatric Emergency Care·Todd Pou-Yen Chang, Cyrus Rangan
Mar 1, 1997·Journal of Pediatric Hematology/oncology·J E LevineP J Giardina
Sep 4, 2001·Human & Experimental Toxicology·D W ChristensenM A Kirby
Jun 6, 2006·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Marjorie S FriesenRobert D Gair
Jan 1, 1991·Critical Reviews in Toxicology·M M Jones
Jan 1, 1996·Journal of Toxicology. Clinical Toxicology·M Tenenbein
Jul 19, 2011·Pediatric Hematology and Oncology·Meropi DimitriadouMiranda Athanassiou-Metaxa
Apr 25, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Laurence DubourgPierre Cochat
Mar 13, 2013·Annals of Laboratory Medicine·Jung Hyun KangSung Joon Shin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.